Skip to main content
KoBioLabs, Inc. logo

KoBioLabs, Inc. — Investor Relations & Filings

Ticker · 348150 ISIN · KR7348150004 KO Manufacturing
Open in API
Filings indexed 174 across all filing types
Latest filing 2022-03-30 Board/Management Inform…
Country KR South Korea
Listing KO 348150

About KoBioLabs, Inc.

http://kobiolabs.com/en/

KoBioLabs, Inc. is a biotechnology company that develops innovative microbiome-based therapeutics. The company utilizes its proprietary Smartiome® platform, an integrated system for discovering novel drug candidates that employs AI-driven multi-omics analysis and a comprehensive microbiome library with a reverse-translation approach. KoBioLabs is focused on creating a pipeline of new drugs to treat a range of immune, metabolic, and brain disorders. The company also applies advanced technologies, including a microbe-based drug delivery system (mDDS) and biofoundry techniques, to enhance the efficacy of its treatments and address unmet medical needs.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the changes in the board of directors, specifically the appointment of new outside directors following a general meeting. This falls under the category of Board/Management Information (MANG).
2022-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the voting outcomes for various agenda items, including financial statement approval, director appointments, and remuneration limits. This aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2022-03-29 Korean
[기재정정]사업보고서 (2021.12)
Annual Report Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a previously filed 'Business Report' (사업보고서), which is the Korean equivalent of a 10-K. It details specific corrections to sections regarding major products, services, and R&D activities. Since it is a formal amendment to a comprehensive annual financial report, it falls under the category of 10-K filings. FY 2021
2022-03-29 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Kobiolabs regarding a decision to issue new shares through a third-party allocation (유상증자결정). This type of filing, which details capital structure changes, share issuance, and the purpose of the capital raise, falls under the category of share issuance and capital changes.
2022-03-29 Korean
본점소재지변경
Regulatory Filings Classification · 100% confidence The document is a short, formal announcement regarding a change in the company's registered office address (본점소재지변경). It provides specific details such as the old address, new address, reason for change, and the date of the board resolution. Since this is a standard regulatory disclosure regarding corporate administrative changes that does not fit into specific categories like financial reports, dividends, or share transactions, it is classified as a general regulatory filing.
2022-03-29 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) meeting (기업설명회). It provides details such as the date, location, purpose, and method (NDR - Non-Deal Roadshow). Since it is an announcement of an event and the availability of IR materials rather than the presentation itself, and it does not fit into specific categories like 10-K or ER, it is classified as a Regulatory Filing (RNS) as it serves as a general corporate disclosure.
2022-03-24 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.